Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
Trade secret
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
Trade secret
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
Trade secret
EC/CAS
50-70-4
Name of the chemical
D-glucitol C6H14O6
Concentration
Trade secret
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
Trade secret
General Information
Revision date
2009-06-15
Product name
Triaminic Flu, Cough & Fever
supplier name
Health, Safety & Environmental Dept
Manufacturer Name
Novartis Consumer Health, Inc
Icons in SDS
Company Information
company name
Novartis Consumer Health, Inc
Section 2
SECTION 2: Hazards identification
Emergency Overview Clear red liquid with bubble gum odor. May cause eye irritation – avoid eye contact. Not expected to present a health, flammability, or reactivity hazard. Avoid release to the environment. Hazard Rating System (HMIS) Health = 1 Flammability = 0 Physical Hazard = 0
Potential health effects
Eyes This product may cause eye irritation. Skin Irritation/Sensitization/ This product is not expected to be irritating to the skin, cause Absorption skin sensitization, or be absorbed through the skin. Ingestion This product is not expected to be harmful by ingestion. Over ingestion of this product may cause adverse effects including central nervous system effects and lethargy. Inhalation This product is not expected to be harmful by inhalation. Inhalation of excessive amounts may cause adverse effects. Subchronic Toxicity There are no subchronic toxicity data on this product. Based on the data of the individual components, the subchronic toxicity of this product is expected to be moderately low. Reproductive Toxicity There are no reproductive toxicity data on this product. Based on the data of the individual components, this product is not expected to present a reproductive toxicity hazard. Teratogenicity (birth defects) There are no teratogenicity data on this product. Based on the data of the individual components, this product is not expected to present a teratogenicity hazard. However, as with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product. Mutagenicity There are no mutagenicity data on this product. Based on the data of the individual components, this product is not expected to present a mutagenicity hazard. Chronic Effects/Carcinogenicity There are no chronic effects or carcinogenicity data on this product. Based on the data of the individual components, this product is not expected to present a chronic or carcinogenicity hazard. · NTP: Not listed · IARC: Not listed
Medical Conditions Generally Aggravated by Exposure
Not available. Exposure Incompatibility Do not use this product while taking a prescription monoamine oxidase inhibitor [MAOI], tricyclic anti- depressant, or selective serotonin reuptake inhibitor (i.e., certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease) even after 21 days after succession. Signs & Symptoms of Exposure Exposure may cause eye irritation. Excessive exposure may cause central nervous system effects and lethargy.